Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

HOME | CONTACT | PATIENT LOGIN | CLINIC LOGIN | FAQ

TRIAL ALERTS

Site Listing

Please choose the site that is most convenient for you

Study Name: Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
5 locations found

Dana-Farber Cancer Institute
Location: Boston, Massachusetts 02115
Ohio State University
Location: Columbus, Ohio 43210
Mayo Clinic
Location: Rochester, Minnesota 55905
Washington University School of Medicine
Location: Saint Louis, Missouri 63110
Mayo Clinic in Arizona
Location: Scottsdale, Arizona 85259

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.

TRIAL ALERTS

HEALTH NEWS

RSS FEEDS

ABOUT TRIALS

LINK TO US

Site Listing